{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:02:11Z","timestamp":1780423331665,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.nano.2018.04.016","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T08:43:18Z","timestamp":1525077798000},"page":"1655-1665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins"],"prefix":"10.1016","volume":"14","author":[{"given":"Zongmin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Pentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Ehrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2018.04.016_bb0005","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra0809890","article-title":"Nicotine addiction","volume":"362","author":"Benowitz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2018.04.016_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-med-111314-033712","article-title":"The past, present, and future of nicotine addiction therapy","volume":"67","author":"Prochaska","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.nano.2018.04.016_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tips.2010.12.008","article-title":"Treatment of nicotine addiction: present therapeutic options and pipeline developments","volume":"32","author":"Polosa","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nano.2018.04.016_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbb.2009.01.015","article-title":"Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence","volume":"92","author":"Moreno","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.nano.2018.04.016_bb0025","first-page":"553","article-title":"New directions in nicotine vaccine design and use. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse","volume":"69","author":"Pentel","year":"2014"},{"key":"10.1016\/j.nano.2018.04.016_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178835","article-title":"Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides","volume":"12","author":"Zeigler","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2018.04.016_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2016.e00147","article-title":"Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the adjuvant Finlay Proteoliposome (AFPL1)","volume":"2","author":"Fraleigh","year":"2016","journal-title":"Heliyon"},{"key":"10.1016\/j.nano.2018.04.016_bb0040","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1021\/jm501625j","article-title":"A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacity","volume":"58","author":"Lockner","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2018.04.016_bb0045","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1021\/acs.jmedchem.5b01676","article-title":"Investigations of enantiopure nicotine haptens using an adjuvanting carrier in anti-nicotine vaccine development","volume":"59","author":"Jacob","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2018.04.016_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002547","article-title":"A vaccine against nicotine for smoking cessation: a randomized controlled trial","volume":"3","author":"Cornuz","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2018.04.016_bb0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"Hatsukami","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nano.2018.04.016_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/hv.22060","article-title":"Nicotine vaccines to treat tobacco dependence","volume":"9","author":"Goniewicz","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nano.2018.04.016_bb0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11599900-000000000-00000","article-title":"Nicotine vaccines to assist with smoking cessation: current status of research","volume":"72","author":"Raupach","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2018.04.016_bb0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/hv.26635","article-title":"A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle","volume":"10","author":"Hu","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nano.2018.04.016_bb0075","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1166\/jbn.2015.2156","article-title":"Negatively charged carbon nanohorn supported cationic liposome nanoparticles: a novel delivery vehicle for anti-nicotine vaccine","volume":"11","author":"Zheng","year":"2015","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.nano.2018.04.016_bb0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nano.2016.07.015","article-title":"A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy","volume":"13","author":"Zhao","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2018.04.016_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.biomaterials.2016.08.028","article-title":"The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine","volume":"106","author":"Hu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2018.04.016_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biomaterials.2017.01.038","article-title":"Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: a focus on hapten density","volume":"123","author":"Zhao","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2018.04.016_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biomaterials.2017.05.031","article-title":"Rationalization of a nanoparticle-based nicotine nanovaccine as an effective next-generation nicotine vaccine: a focus on hapten localization","volume":"138","author":"Zhao","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2018.04.016_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biomaterials.2017.11.021","article-title":"Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction","volume":"155","author":"Zhao","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2018.04.016_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A brief history of T cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2018.04.016_bb0110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nano.2018.04.016_bb0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/bc500016k","article-title":"Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse","volume":"25","author":"Collins","year":"2014","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2018.04.016_bb0120","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.vaccine.2014.02.024","article-title":"Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates","volume":"32","author":"Fraser","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2018.04.016_bb0125","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.196.Supp.76.16","article-title":"Performance of keyhole limpet hemocyanin (KLH) as an antigen carrier for protein antigens depends on KLH property and conjugation route","volume":"196","author":"Bi","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2018.04.016_bb0130","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.1501156","article-title":"Hemocyanins stimulate innate immunity by inducing different temporal patterns of proinflammatory cytokine expression in macrophages","volume":"196","author":"Zhong","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2018.04.016_bb0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.intimp.2015.09.012","article-title":"Anti-nicotine vaccines: comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates","volume":"29","author":"McCluskie","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2018.04.016_bb0140","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/ajad.12307","article-title":"Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine","volume":"24","author":"Haile","year":"2015","journal-title":"Am J Addict"},{"key":"10.1016\/j.nano.2018.04.016_bb0145","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1016\/j.vaccine.2013.10.051","article-title":"Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum","volume":"31","author":"de Villiers","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2018.04.016_bb0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.addr.2004.09.008","article-title":"Immunity in response to particulate antigen-delivery systems","volume":"57","author":"Storni","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2018.04.016_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2016.05.033","article-title":"Orchestrating immune responses: how size, shape and rigidity affect the immunogenicity of particulate vaccines","volume":"234","author":"Benne","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2018.04.016_bb0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.drudis.2011.04.006","article-title":"Particulate vaccines: on the quest for optimal delivery and immune response","volume":"16","author":"De Temmerman","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2018.04.016_bb0165","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1021\/nn400334y","article-title":"Single-step assembly of DOX\/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy","volume":"7","author":"Zheng","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2018.04.016_bb0170","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/nn800275r","article-title":"Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform","volume":"2","author":"Zhang","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2018.04.016_bb0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.actbio.2015.09.032","article-title":"Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability","volume":"28","author":"Hu","year":"2015","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2018.04.016_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.polymer.2015.10.048","article-title":"In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles","volume":"80","author":"Hu","year":"2015","journal-title":"Polymer"},{"key":"10.1016\/j.nano.2018.04.016_bb0185","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2018.04.016_bb0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nano.2012.11.010","article-title":"Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform","volume":"9","author":"Mandal","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2018.04.016_bb0195","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2018.04.016_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0065-2776(08)60662-8","article-title":"Control of the immune-response at the level of antigen-presenting cells - a comparison of the function of dendritic cells and lymphocytes-B","volume":"47","author":"Metlay","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1016\/j.nano.2018.04.016_bb0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.nano.2018.04.016_bb0210","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0968-4328(99)00036-0","article-title":"Keyhole limpet hemocyanin (KLH): a biomedical review","volume":"30","author":"Harris","year":"1999","journal-title":"Micron"},{"key":"10.1016\/j.nano.2018.04.016_bb0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Broker","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.nano.2018.04.016_bb0220","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nano.2018.04.016_bb0225","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1021\/nl301877k","article-title":"A DNA nanostructure platform for directed sssembly of synthetic vaccines","volume":"12","author":"Liu","year":"2012","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2018.04.016_bb0230","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tips.2015.07.002","article-title":"Biologic approaches to treat substance-use disorders","volume":"36","author":"Skolnick","year":"2015","journal-title":"Trends Pharmacol Sci"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418300881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963418300881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:10:54Z","timestamp":1761549054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963418300881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1549963418300881"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2018.04.016","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2018.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}